

TURP (Transurethral Resection of Prostate) Success Rate in India
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Understanding TURP (Transurethral Resection of Prostate) Success Rate in India
For individuals considering prostate treatment, understanding the TURP (Transurethral Resection of Prostate) success rate in India is crucial. Success in medical procedures like TURP depends significantly on the patient's specific condition, the underlying diagnosis, and the expertise of the medical team. India has emerged as a prominent destination for various healthcare treatments, offering a comprehensive review of outcomes.
Outcomes for TURP (Transurethral Resection of Prostate) in India are evaluated through aggregated clinical data, allowing for a clear understanding of typical results. These success trends highlight how outcomes can vary based on patient demographics and specific procedural nuances. This information aids patients in making informed decisions about their healthcare journey.
Defining Success in TURP Outcomes
For TURP (Transurethral Resection of Prostate), "success" primarily indicates significant improvement in bothersome urinary symptoms, enhanced urinary flow, and a reduction in post-void residual urine. It also encompasses improved quality of life and minimized long-term complications. Success is often assessed both immediately post-procedure and over an extended period, reflecting short-term relief versus sustained benefits.
TURP (Transurethral Resection of Prostate) Success Rate Breakdown
TURP (Transurethral Resection of Prostate) success rates vary depending on patient-specific factors and the primary outcome being measured.
| Outcome Metric | Typical Indication | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Symptomatic Improvement | Moderate to severe BPH symptoms | 80%–95% | Significant reduction in urinary frequency, urgency, nocturia. |
| Improved Urinary Flow | Poor urine stream, incomplete emptying | 75%–90% | Increased peak urinary flow rate and reduced residual urine volume. |
| Reduced Re-intervention | Long-term BPH management | 85%–95% (over 5 years) | Avoiding need for repeat surgery or retreatment for BPH. |
| Long-term Quality of Life | Overall patient satisfaction | 85%–95% | Sustained relief and improved daily living without bothersome urinary issues. |
TURP (Transurethral Resection of Prostate) Survival Rate by Age in India
| Age Group / Patient Category | Primary Consideration | TURP (Transurethral Resection of Prostate) Survival Rate in India Range (%) |
|---|---|---|
| Younger Patients (<65 years) | Minimal comorbidities, active lifestyle | 98%–99% |
| Middle-aged Patients (65-75 years) | Moderate comorbidities, stable health | 96%–98% |
| Elderly Patients (>75 years) | Higher comorbidity burden, careful selection | 94%–97% |
| Patients with Specific Comorbidities | Cardiac, renal, or significant respiratory issues | Varies significantly based on condition |
TURP (Transurethral Resection of Prostate) Recovery Rate in India vs. Global Outcomes
The TURP (Transurethral Resection of Prostate) recovery rate in India generally aligns with international benchmarks, reflecting similar protocols and technological advancements. Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols, contributing to comparable outcomes observed globally, especially when considering similar patient profiles and disease severity.
| Country | TURP (Transurethral Resection of Prostate) Success Rate Range (%) |
|---|---|
| India | 80%–95% |
| United States | 85%–96% |
| United Kingdom | 80%–94% |
| Germany | 82%–95% |
| Singapore | 83%–95% |
| South Korea | 80%–93% |
| Thailand | 78%–92% |
Success rates presented are indicative and not guaranteed, varying based on individual patient health and specific treatment approaches.
Factors Influencing TURP (Transurethral Resection of Prostate) Success Rate in India
- Severity and Type of BPH: The prostate's size, pattern of enlargement (e.g., median lobe), and presence of complications.
- Patient's Age and Overall Health: Older patients or those with multiple comorbidities may experience different recovery trajectories. This impacts stage wise TURP (Transurethral Resection of Prostate) survival rate in India.
- Surgeon's Experience and Technique: The skill and volume of procedures performed by the operating surgeon can significantly affect outcomes.
- Pre-operative Assessment: Thorough evaluation ensures appropriate patient selection and optimizes the procedural approach.
- Post-operative Care and Adherence: Following recovery guidelines, including medication and lifestyle adjustments, supports better long-term results.
Data Sources and Methodology for TURP Outcome Analysis
- Aggregated data from national healthcare registries and large multi-hospital databases across India.
- Findings from peer-reviewed medical studies and clinical trials published in urology journals.
- Reports and statistical analyses from international health organizations focusing on urological procedures.
- Outcome data collected through systematic reviews and meta-analyses of existing medical literature.
Informed Choices for Prostate Health
Understanding TURP outcomes empowers patients to make informed decisions about their treatment journey. Consulting with healthcare professionals offers personalized guidance based on individual health profiles and specific needs.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

Artemis Hospital
Sector 51, Gurugram, Haryana, India

Lokmanya Hospitals
Not Specified

White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India

Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists




Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India





Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India

How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.